This brings the total sum raised by the company, which rose to prominence during the Coronavirus pandemic, to $85 million
Diagnostic Robotics, an Israeli company which employs advanced AI and predictive analytical models in clinical diagnostic systems, raised $45 million in Series B. This brings the total sum raised by the company to $85 million.
Diagnostic Robotics offers customized digital health solutions for governments, providers, employers and individuals, and has a self-professed quadruple aim: reduce per capita spending, improve outcomes for populations, and improve experiences for both patients and healthcare providers.
“We reduce health system overload by helping individuals determine the right course of action while minimizing direct contact with medical teams,” states the company website. This has become especially useful during the Covid-19 pandemic, when Diagnostic Robotics developed a remote assessment and monitoring tool which included automated patient queries, necessary alerts, and daily updates about the spread and progress of the disease at both the community and regional levels.
The company was founded in 2017 by Dr. Kira Radinsky (CEO), Yonatan Amir (President), and Prof. Moshe Shoham (Engineering Director). It employs some 60 staff members in Israel and in the US.
35-year-old Radinsky is somewhat of a celebrity in Israel, and one of the country’s best-known scientists to the general population. She previously worked as Chief Scientist & Director of Data Science at eBay Israel, and was included in MIT Tech Review’s “35 Innovators Under 35” and in Forbes’ “30 Under 30” list.